Pavmed Inc.-CW24PAVMZPreferred / convertible
13F holders, Q3 2024 (September 30)3holders
0new positions
0sold out
1famous investor
$0.02avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Pavmed Inc.-CW24 (PAVMZ) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($918), UBS Group AG ($178) and Bank of America Corp. ($2). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Pavmed Inc.-CW24
- CUSIP
- 70387R122
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 8,341 shares bought, net +8,341 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | — | Add +1.1% | 42,692 | $918 |
| UBS Group AG | — | Add +1309.5% | 8,457 | $178 |
| Bank of America Corp. | — | No change | 100 | $2 |
"% of holder's portfolio" is PAVMZ's weight in each manager's 13F, not the share of Pavmed Inc.-CW24 the manager owns.